Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriella Dardanoni

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
European Journal of Internal Medicine|June 24, 2018
β-Thalassemia heterozygote state detrimentally affects health expectationLuciano Graffeo, Angela Vitrano, Salvatore Scondotto, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2002
p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-upAntonio Russo, Manuela Migliavacca, Ines Zanna, et al.
Journal of Cellular Physiology|June 18, 2002
Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?Viviana Bazan, Manuela Migliavacca, Carla Tubiolo, et al.
Journal of Cellular Physiology|June 21, 2005
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinomaAntonio Russo, Simona Corsale, Valentina Agnese, et al.
Journal of Cellular Physiology|July 16, 2004
TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcomeManuela Migliavacca, Laura Ottini, Viviana Bazan, et al.
Journal of Cellular Physiology|July 19, 2002
Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinomaViviana Bazan, Ines Zanna, Manuela Migliavacca, et al.
British Journal of Haematology|November 20, 2020
A complication risk score to evaluate clinical severity of thalassaemia syndromesAngela Vitrano, Antonella Meloni, Walter Addario Pollina, et al.
Oncology Reports|July 29, 2003
Nm23-H1 expression does not predict clinical survival in colorectal cancer patientsLuisa Dusonchet, Simona Corsale, Manuela Migliavacca, et al.
British Journal of Haematology|October 26, 2021
Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemiaKhaled M Musallam, Angela Vitrano, Antonella Meloni, et al.
Blood Cells, Molecules & Diseases|December 4, 2022
Development of a Thalassemia International Prognostic Scoring System (TIPSS)Angela Vitrano, Khaled M Musallam, Antonella Meloni, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Internal Medicine|June 24, 2018
β-Thalassemia heterozygote state detrimentally affects health expectationLuciano Graffeo, Angela Vitrano, Salvatore Scondotto, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2002
p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-upAntonio Russo, Manuela Migliavacca, Ines Zanna, et al.
Journal of Cellular Physiology|June 18, 2002
Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?Viviana Bazan, Manuela Migliavacca, Carla Tubiolo, et al.
Journal of Cellular Physiology|June 21, 2005
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinomaAntonio Russo, Simona Corsale, Valentina Agnese, et al.
Journal of Cellular Physiology|July 16, 2004
TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcomeManuela Migliavacca, Laura Ottini, Viviana Bazan, et al.
Journal of Cellular Physiology|July 19, 2002
Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinomaViviana Bazan, Ines Zanna, Manuela Migliavacca, et al.
British Journal of Haematology|November 20, 2020
A complication risk score to evaluate clinical severity of thalassaemia syndromesAngela Vitrano, Antonella Meloni, Walter Addario Pollina, et al.
Oncology Reports|July 29, 2003
Nm23-H1 expression does not predict clinical survival in colorectal cancer patientsLuisa Dusonchet, Simona Corsale, Manuela Migliavacca, et al.
British Journal of Haematology|October 26, 2021
Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemiaKhaled M Musallam, Angela Vitrano, Antonella Meloni, et al.
Blood Cells, Molecules & Diseases|December 4, 2022
Development of a Thalassemia International Prognostic Scoring System (TIPSS)Angela Vitrano, Khaled M Musallam, Antonella Meloni, et al.
Pageof 4